Patents by Inventor Jeffrey Louis Goldberg

Jeffrey Louis Goldberg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GROWTH AND DIFFERENTIATION FACTOR 15 FOR TREATMENT OF PROLIFERATIVE VITREORETINOPATHY THERAPY
    Publication number: 20240000891
    Abstract: An effective dose of Growth Differentiation Factor 15 (GDF15) is used for prevention or treatment of proliferative vitreoretinopathy. Specifically, the disclosure provides methods and compositions for treatment of proliferative vitreoretinopathy (PVR), which is based on preventing or reducing proliferation, cell migration, or epithelial-mesenchymal transition (EMT) of epithelial cells involved in PVR.
    Type: Application
    Filed: December 7, 2021
    Publication date: January 4, 2024
    Inventors: Jeffrey Louis Goldberg, Kun-Che Chang
  • USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
    Publication number: 20220071897
    Abstract: Described herein are methods and devices for the long term treatment of ophthalmic disorders. Also disclosed are encapsulated cell therapy (ECT) devices that secrete a biologically active molecule and methods for using the same for the treatment of various kinds of ophthalmic disorders, including retinitis pigmentosa, geographic atrophy (dry age-related macular degeneration), glaucoma and/or macular telangiectasia.
    Type: Application
    Filed: November 18, 2021
    Publication date: March 10, 2022
    Inventors: Jeffrey Louis GOLDBERG, Cahil MCGOVERN, Weng TAO, Konrad A. KAUPER
  • Use of encapsulated cell therapy for treatment of ophthalmic disorders
    Patent number: 11207266
    Abstract: Described herein are methods and devices for the long term treatment of ophthalmic disorders. Also disclosed are encapsulated cell therapy (ECT) devices that secrete a biologically active molecule and methods for using the same for the treatment of various kinds of ophthalmic disorders, including retinitis pigmentosa, geographic atrophy (dry age-related macular degeneration), glaucoma and/or macular telangiectasia.
    Type: Grant
    Filed: September 6, 2019
    Date of Patent: December 28, 2021
    Assignee: Neurotech, USA, Inc.
    Inventors: Jeffrey Louis Goldberg, Cahil McGovern, Weng Tao, Konrad A. Kauper
  • USE OF ENCAPSULATED CELL THERAPY FOR TREATMENT OF OPHTHALMIC DISORDERS
    Publication number: 20200197297
    Abstract: Described herein are methods and devices for the long term treatment of ophthalmic disorders. Also disclosed are encapsulated cell therapy (ECT) devices that secrete a biologically active molecule and methods for using the same for the treatment of various kinds of ophthalmic disorders, including retinitis pigmentosa, geographic atrophy (dry age-related macular degeneration), glaucoma and/or macular telangiectasia.
    Type: Application
    Filed: September 6, 2019
    Publication date: June 25, 2020
    Inventors: Jeffrey Louis GOLDBERG, Cahil MCGOVERN, Weng TAO, Konrad A. KAUPER
  • Use of encapsulated cell therapy for treatment of ophthalmic disorders
    Patent number: 10456356
    Abstract: Described herein are methods and devices for the long term treatment of ophthalmic disorders. Also disclosed are encapsulated cell therapy (ECT) devices that secrete a biologically active molecule and methods for using the same for the treatment of various kinds of ophthalmic disorders, including retinitis pigmentosa, geographic atrophy (dry age-related macular degeneration), glaucoma and/or macular telangiectasia.
    Type: Grant
    Filed: May 27, 2016
    Date of Patent: October 29, 2019
    Assignee: Neurotech USA, Inc.
    Inventors: Jeffrey Louis Goldberg, Cahil McGovern, Weng Tao, Konrad Kauper
  • SYSTEMS AND METHODS FOR PREDICTIVE VISUAL RENDERING
    Publication number: 20190235624
    Abstract: A method of displaying information to a user includes: tracking the user's eye to obtain information about the time-varying physiology of the user's eye; correlating the information about the time-varying physiology of the user's eye to information about the user's field of view; predicting where the user will look at a future time based on the correlation; and displaying to the user's eye, at the future time, information related to one or more objects in the user's field of view based on the prediction.
    Type: Application
    Filed: July 19, 2017
    Publication date: August 1, 2019
    Applicant: Supereye, Inc.
    Inventors: Jeffrey Louis GOLDBERG, Abraham M. SHER, Daniel A. BOCK, Alfredo DUBRA
  • Methods and Devices for Providing Enhanced Visual Acuity
    Publication number: 20170092007
    Abstract: The specification describes an enhanced reality visual interface in the form of smart eyeglasses that view, process, and project desired visual information to a user's field of view. High resolution picture elements or super-pixels are used to create an enhanced image for a user, based on the user's actual visual acuity and the desired enhanced image. Generated signals are delivered to the eye in a manner that image processing is carried out by the user's brain.
    Type: Application
    Filed: September 23, 2016
    Publication date: March 30, 2017
    Inventors: Jeffrey Louis Goldberg, Abraham M. Sher, Daniel A. Bock
  • Use of Encapsulated Cell Therapy for Treatment of Ophthalmic Disorders
    Publication number: 20160346197
    Abstract: Described herein are methods and devices for the long term treatment of ophthalmic disorders. Also disclosed are encapsulated cell therapy (ECT) devices that secrete a biologically active molecule and methods for using the same for the treatment of various kinds of ophthalmic disorders, including retinitis pigmentosa, geographic atrophy (dry age-related macular degeneration), glaucoma and/or macular telangiectasia.
    Type: Application
    Filed: May 27, 2016
    Publication date: December 1, 2016
    Inventors: Jeffrey Louis Goldberg, Cahil McGovern, Weng Tao, Konrad Kauper